
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Preleukemic mutations in human acute myeloid leukemia affect epigenetic regulators and persist in remission
M. Ryan Corces, Wan‐Jen Hong, Irving L. Weissman, et al.
Proceedings of the National Academy of Sciences (2014) Vol. 111, Iss. 7, pp. 2548-2553
Open Access | Times Cited: 673
M. Ryan Corces, Wan‐Jen Hong, Irving L. Weissman, et al.
Proceedings of the National Academy of Sciences (2014) Vol. 111, Iss. 7, pp. 2548-2553
Open Access | Times Cited: 673
Showing 1-25 of 673 citing articles:
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
Hartmut Döhner, Elihu H. Estey, David Grimwade, et al.
Blood (2016) Vol. 129, Iss. 4, pp. 424-447
Open Access | Times Cited: 5146
Hartmut Döhner, Elihu H. Estey, David Grimwade, et al.
Blood (2016) Vol. 129, Iss. 4, pp. 424-447
Open Access | Times Cited: 5146
Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes
Siddhartha Jaiswal, Pierre Fontanillas, Jason Flannick, et al.
New England Journal of Medicine (2014) Vol. 371, Iss. 26, pp. 2488-2498
Open Access | Times Cited: 4106
Siddhartha Jaiswal, Pierre Fontanillas, Jason Flannick, et al.
New England Journal of Medicine (2014) Vol. 371, Iss. 26, pp. 2488-2498
Open Access | Times Cited: 4106
Genomic Classification and Prognosis in Acute Myeloid Leukemia
Elli Papaemmanuil, Moritz Gerstung, Lars Bullinger, et al.
New England Journal of Medicine (2016) Vol. 374, Iss. 23, pp. 2209-2221
Open Access | Times Cited: 3536
Elli Papaemmanuil, Moritz Gerstung, Lars Bullinger, et al.
New England Journal of Medicine (2016) Vol. 374, Iss. 23, pp. 2209-2221
Open Access | Times Cited: 3536
Clonal Hematopoiesis and Blood-Cancer Risk Inferred from Blood DNA Sequence
Giulio Genovese, Anna K. Kähler, Robert E. Handsaker, et al.
New England Journal of Medicine (2014) Vol. 371, Iss. 26, pp. 2477-2487
Open Access | Times Cited: 3089
Giulio Genovese, Anna K. Kähler, Robert E. Handsaker, et al.
New England Journal of Medicine (2014) Vol. 371, Iss. 26, pp. 2477-2487
Open Access | Times Cited: 3089
Acute Myeloid Leukemia
Hartmut Döhner, Daniel J. Weisdorf, Clara D. Bloomfield
New England Journal of Medicine (2015) Vol. 373, Iss. 12, pp. 1136-1152
Closed Access | Times Cited: 2803
Hartmut Döhner, Daniel J. Weisdorf, Clara D. Bloomfield
New England Journal of Medicine (2015) Vol. 373, Iss. 12, pp. 1136-1152
Closed Access | Times Cited: 2803
Function and information content of DNA methylation
Dirk Schübeler
Nature (2015) Vol. 517, Iss. 7534, pp. 321-326
Closed Access | Times Cited: 1844
Dirk Schübeler
Nature (2015) Vol. 517, Iss. 7534, pp. 321-326
Closed Access | Times Cited: 1844
The Human Cell Atlas
Aviv Regev, Sarah A. Teichmann, Eric S. Lander, et al.
eLife (2017) Vol. 6
Open Access | Times Cited: 1552
Aviv Regev, Sarah A. Teichmann, Eric S. Lander, et al.
eLife (2017) Vol. 6
Open Access | Times Cited: 1552
Lineage-specific and single-cell chromatin accessibility charts human hematopoiesis and leukemia evolution
M. Ryan Corces, Jason D. Buenrostro, Beijing Wu, et al.
Nature Genetics (2016) Vol. 48, Iss. 10, pp. 1193-1203
Open Access | Times Cited: 1100
M. Ryan Corces, Jason D. Buenrostro, Beijing Wu, et al.
Nature Genetics (2016) Vol. 48, Iss. 10, pp. 1193-1203
Open Access | Times Cited: 1100
Efficacy and Biological Correlates of Response in a Phase II Study of Venetoclax Monotherapy in Patients with Acute Myelogenous Leukemia
Marina Konopleva, Daniel A. Pollyea, Jalaja Potluri, et al.
Cancer Discovery (2016) Vol. 6, Iss. 10, pp. 1106-1117
Open Access | Times Cited: 926
Marina Konopleva, Daniel A. Pollyea, Jalaja Potluri, et al.
Cancer Discovery (2016) Vol. 6, Iss. 10, pp. 1106-1117
Open Access | Times Cited: 926
Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party
Gerrit Jan Schuurhuis, Michael Heuser, Sylvie D. Freeman, et al.
Blood (2018) Vol. 131, Iss. 12, pp. 1275-1291
Open Access | Times Cited: 916
Gerrit Jan Schuurhuis, Michael Heuser, Sylvie D. Freeman, et al.
Blood (2018) Vol. 131, Iss. 12, pp. 1275-1291
Open Access | Times Cited: 916
Clonal hematopoiesis in human aging and disease
Siddhartha Jaiswal, Benjamin L. Ebert
Science (2019) Vol. 366, Iss. 6465
Open Access | Times Cited: 835
Siddhartha Jaiswal, Benjamin L. Ebert
Science (2019) Vol. 366, Iss. 6465
Open Access | Times Cited: 835
Prediction of acute myeloid leukaemia risk in healthy individuals
Sagi Abelson, Grace Collord, Stanley Ng, et al.
Nature (2018) Vol. 559, Iss. 7714, pp. 400-404
Open Access | Times Cited: 741
Sagi Abelson, Grace Collord, Stanley Ng, et al.
Nature (2018) Vol. 559, Iss. 7714, pp. 400-404
Open Access | Times Cited: 741
Assessment of Minimal Residual Disease in Standard-Risk AML
Adam Ivey, Robert K. Hills, Michael A. Simpson, et al.
New England Journal of Medicine (2016) Vol. 374, Iss. 5, pp. 422-433
Open Access | Times Cited: 737
Adam Ivey, Robert K. Hills, Michael A. Simpson, et al.
New England Journal of Medicine (2016) Vol. 374, Iss. 5, pp. 422-433
Open Access | Times Cited: 737
Clonal hematopoiesis, with and without candidate driver mutations, is common in the elderly
Florian Zink, Simon Stacey, Gudmundur L. Norddahl, et al.
Blood (2017) Vol. 130, Iss. 6, pp. 742-752
Open Access | Times Cited: 691
Florian Zink, Simon Stacey, Gudmundur L. Norddahl, et al.
Blood (2017) Vol. 130, Iss. 6, pp. 742-752
Open Access | Times Cited: 691
Prognostic Mutations in Myelodysplastic Syndrome after Stem-Cell Transplantation
R. Coleman Lindsley, Wael Saber, Brenton G. Mar, et al.
New England Journal of Medicine (2017) Vol. 376, Iss. 6, pp. 536-547
Open Access | Times Cited: 682
R. Coleman Lindsley, Wael Saber, Brenton G. Mar, et al.
New England Journal of Medicine (2017) Vol. 376, Iss. 6, pp. 536-547
Open Access | Times Cited: 682
The genetics of myelodysplastic syndrome: from clonal haematopoiesis to secondary leukaemia
Adam S. Sperling, Christopher J. Gibson, Benjamin L. Ebert
Nature reviews. Cancer (2016) Vol. 17, Iss. 1, pp. 5-19
Open Access | Times Cited: 603
Adam S. Sperling, Christopher J. Gibson, Benjamin L. Ebert
Nature reviews. Cancer (2016) Vol. 17, Iss. 1, pp. 5-19
Open Access | Times Cited: 603
Isocitrate dehydrogenase 1 and 2 mutations induce BCL-2 dependence in acute myeloid leukemia
Steven M. Chan, Danièl Thomas, M. Ryan Corces, et al.
Nature Medicine (2015) Vol. 21, Iss. 2, pp. 178-184
Open Access | Times Cited: 527
Steven M. Chan, Danièl Thomas, M. Ryan Corces, et al.
Nature Medicine (2015) Vol. 21, Iss. 2, pp. 178-184
Open Access | Times Cited: 527
Tracing the origins of relapse in acute myeloid leukaemia to stem cells
Liran I. Shlush, Amanda Mitchell, Lawrence E. Heisler, et al.
Nature (2017) Vol. 547, Iss. 7661, pp. 104-108
Closed Access | Times Cited: 499
Liran I. Shlush, Amanda Mitchell, Lawrence E. Heisler, et al.
Nature (2017) Vol. 547, Iss. 7661, pp. 104-108
Closed Access | Times Cited: 499
Genomics of Acute Myeloid Leukemia Diagnosis and Pathways
Lars Bullinger, Konstanze Döhner, Hartmut Döhner
Journal of Clinical Oncology (2017) Vol. 35, Iss. 9, pp. 934-946
Closed Access | Times Cited: 441
Lars Bullinger, Konstanze Döhner, Hartmut Döhner
Journal of Clinical Oncology (2017) Vol. 35, Iss. 9, pp. 934-946
Closed Access | Times Cited: 441
DNMT3A in haematological malignancies
Liubin Yang, Rachel E. Rau, Margaret A. Goodell
Nature reviews. Cancer (2015) Vol. 15, Iss. 3, pp. 152-165
Open Access | Times Cited: 429
Liubin Yang, Rachel E. Rau, Margaret A. Goodell
Nature reviews. Cancer (2015) Vol. 15, Iss. 3, pp. 152-165
Open Access | Times Cited: 429
Biology and relevance of human acute myeloid leukemia stem cells
Danièl Thomas, Ravindra Majeti
Blood (2017) Vol. 129, Iss. 12, pp. 1577-1585
Open Access | Times Cited: 418
Danièl Thomas, Ravindra Majeti
Blood (2017) Vol. 129, Iss. 12, pp. 1577-1585
Open Access | Times Cited: 418
Quiescent Hematopoietic Stem Cells Accumulate DNA Damage during Aging that Is Repaired upon Entry into Cell Cycle
Isabel Beerman, Jun Seita, Matthew A. Inlay, et al.
Cell stem cell (2014) Vol. 15, Iss. 1, pp. 37-50
Open Access | Times Cited: 408
Isabel Beerman, Jun Seita, Matthew A. Inlay, et al.
Cell stem cell (2014) Vol. 15, Iss. 1, pp. 37-50
Open Access | Times Cited: 408
Clonal Hematopoiesis and Evolution to Hematopoietic Malignancies
Robert L. Bowman, Lambert Busque, Ross L. Levine
Cell stem cell (2018) Vol. 22, Iss. 2, pp. 157-170
Open Access | Times Cited: 408
Robert L. Bowman, Lambert Busque, Ross L. Levine
Cell stem cell (2018) Vol. 22, Iss. 2, pp. 157-170
Open Access | Times Cited: 408
Molecular landscape of acute myeloid leukemia in younger adults and its clinical relevance
David Grimwade, Adam Ivey, Brian J.P. Huntly
Blood (2015) Vol. 127, Iss. 1, pp. 29-41
Open Access | Times Cited: 400
David Grimwade, Adam Ivey, Brian J.P. Huntly
Blood (2015) Vol. 127, Iss. 1, pp. 29-41
Open Access | Times Cited: 400
AG-221, a First-in-Class Therapy Targeting Acute Myeloid Leukemia Harboring Oncogenic IDH2 Mutations
Katharine Yen, Jeremy Travins, Fang Wang, et al.
Cancer Discovery (2017) Vol. 7, Iss. 5, pp. 478-493
Open Access | Times Cited: 399
Katharine Yen, Jeremy Travins, Fang Wang, et al.
Cancer Discovery (2017) Vol. 7, Iss. 5, pp. 478-493
Open Access | Times Cited: 399